Treatment of Localized Epithelioma (Basal Cell Carcinoma)
For localized epithelioma (basal cell carcinoma), surgical excision with margin assessment or Mohs micrographic surgery is the first-line treatment, offering the highest cure rates (>95%) and lowest recurrence rates. 1, 2
Risk Stratification Determines Treatment Approach
Treatment selection depends critically on whether the tumor is classified as low-risk or high-risk based on size, location, histologic subtype, and whether it's primary or recurrent 1, 2.
Low-Risk BCC Treatment Options
For low-risk tumors (small, well-defined, on trunk/extremities, nodular subtype):
- Standard excision with 4-mm clinical margins is appropriate when linear closure, second intention healing, or skin graft can be performed 2
- Curettage and electrodesiccation (C&E) achieves excellent cure rates for carefully selected low-risk lesions, particularly on trunk and extremities, but should be avoided in:
- Terminal hair-bearing areas (scalp, pubic, axillary, beard regions) due to follicular tumor extension
- Cosmetically sensitive areas due to inferior cosmetic outcomes and longer healing times 1
- Radiation therapy is reserved for nonsurgical candidates, typically patients >60 years old, with 5-year recurrence rates of 7.5% 2, 3
High-Risk BCC Treatment Options
For high-risk tumors (large, poorly defined, on face/ears/genitals, aggressive histology, recurrent):
- Mohs micrographic surgery (MMS) is the gold standard, offering:
- Excision with complete circumferential peripheral and deep margin assessment (CCPDMA) is an acceptable alternative to MMS 2
When Surgery Is Not Feasible
Superficial therapies should only be used when surgery or radiation is contraindicated or impractical, as cure rates are lower 1, 2:
Topical Therapies (for superficial BCC only)
- Imiquimod cream: 84% clinical success rate at 3 years, with excellent/good cosmetic outcomes in 61% 2
- 5-Fluorouracil cream: Similar efficacy to imiquimod 2
- Both cause moderate-to-severe local skin reactions (redness, swelling, erosions, crusting) 1
Photodynamic Therapy (PDT)
- 73% treatment success rate for superficial BCC, inferior to imiquimod (80%) 2
- Better cosmetic outcomes than cryotherapy but causes significant pain during treatment 2
- Higher cure rates for superficial versus nodular subtypes 2
Cryosurgery
- Recurrence rates range from 6.3% to 39% depending on operator skill and patient selection 1, 2
- Poorer cosmetic outcomes compared to other modalities 2
- Should only be considered when more effective therapies are contraindicated 1
Critical Management Principles
If margins are positive after excision, adjuvant therapy is mandatory: re-excision with MMS/CCPDMA, or radiation therapy 2. Radiation therapy is also indicated for substantial perineural involvement (large nerve involvement) 2.
Radiation therapy is absolutely contraindicated in genetic conditions predisposing to skin cancer (basal cell nevus syndrome, xeroderma pigmentosum) and connective tissue diseases (lupus, scleroderma) 2.
Common Pitfalls to Avoid
- Do not use C&E in hair-bearing areas or cosmetically sensitive locations
- Do not rely on superficial therapies for nodular or infiltrative subtypes
- Do not use cryosurgery as first-line treatment when surgical options are available
- Ensure complete margin assessment after any excision—positive margins require immediate re-treatment
Follow-Up Requirements
Patients require surveillance every 6-12 months for the first 2 years, as 30-50% will develop another BCC within 5 years (10-fold increased risk versus general population) 2. After 2 years without recurrence, exam frequency may be reduced.